The present study identified the novel role of PKA in homologous desensitization of VPAC2 receptors via the phosphorylation of GRK2 at Ser 685 . VIP induced phosphorylation of GRK2 in a concentrationdependent fashion, and the phosphorylation was abolished by blockade of PKA with cell-permeable myristoylated protein kinase inhibitor (PKI) or in cells expressing PKA phosphorylation-site deficient GRK2(S685A). Phosphorylation of GRK2 increased its activity and binding to G␤␥. VIP-induced phosphorylation of VPAC2 receptors was abolished in muscle cells expressing kinase-deficient GRK2(K220R) and attenuated in cells expressing GRK2(S685A) or by PKI. VPAC2 receptor internalization (determined from residual 125 I-labeled VIP binding and receptor biotinylation after a 30-min exposure to VIP) was blocked in cells expressing GRK2(K220R) and attenuated in cells expressing GRK2(S685A) or by PKI. Finally, VPAC2 receptor degradation (determined from residual 125 I-labeled VIP binding and receptor expression after a prolonged exposure to VIP) and functional VPAC2 receptor desensitization (determined from the decrease in adenylyl cyclase activity and cAMP formation after a 30-min exposure to VIP) were abolished in cells expressing GRK2(K220R) and attenuated in cells expressing GRK2(S685A). These results demonstrate that in gastric smooth muscle VPAC2 receptor phosphorylation is mediated by GRK2. Phosphorylation of GRK2 by PKA enhances GRK2 activity and its ability to induce VPAC2 receptor phosphorylation, internalization, desensitization, and degradation. homologous desensitization; vasoactive intestinal peptide; G proteincoupled receptor kinase; gastric muscle; G protein signaling; pituitary adenylate cyclase-activating peptide HOMOLOGOUS DESENSITIZATION of agonist-occupied receptors is initiated upon receptor phosphorylation by G protein-coupled receptor kinase (GRK) (19, 37, 38) . Binding of phosphorylated receptors to ␤-arrestin uncouples the receptors from the G proteins and targets the receptors to clathrin-coated pits. ␤-Arrestin acts as a scaffold for other proteins including the terminal components of MAPKs and the cytosolic tyrosine kinase c-Src; the latter stimulates tyrosine phosphorylation of the large GTPase dynamin and promotes its ability to cleave clathrin-coated vesicles from the cell surface (20 -23, 38). The vesicles fuse with endosomes, where the receptors are dephosphorylated and either slowly or rapidly recycled to the surface. Some receptors, however, are partly or wholly internalized via a clathrin-independent caveolar pathway involving the phosphorylation of dynamin and caveolin by c-Src (1, 2, 18, 40).
HOMOLOGOUS DESENSITIZATION of agonist-occupied receptors is initiated upon receptor phosphorylation by G protein-coupled receptor kinase (GRK) (19, 37, 38) . Binding of phosphorylated receptors to ␤-arrestin uncouples the receptors from the G proteins and targets the receptors to clathrin-coated pits. ␤-Arrestin acts as a scaffold for other proteins including the terminal components of MAPKs and the cytosolic tyrosine kinase c-Src; the latter stimulates tyrosine phosphorylation of the large GTPase dynamin and promotes its ability to cleave clathrin-coated vesicles from the cell surface (20 -23, 38) . The vesicles fuse with endosomes, where the receptors are dephosphorylated and either slowly or rapidly recycled to the surface. Some receptors, however, are partly or wholly internalized via a clathrin-independent caveolar pathway involving the phosphorylation of dynamin and caveolin by c-Src (1, 2, 18, 40) .
A role for second messenger-activated protein kinases, such as PKC or PKA, in receptor phosphorylation and/or internalization is highly variable and may depend on the cell type in which the receptor is expressed (9, 11, 39) . ␤ 2 -Adrenergic receptors (␤ 2 ARs) are preferentially phosphorylated by PKA at low agonist concentrations and by both PKA and GRK2 at higher agonist concentrations; in addition, PKA phosphorylates GRK2 and enhances its activity (4, 7, 10, 45) . Both kinases together with the receptor and other signaling molecules are bound to A kinase-achoring protein 79, a PKAanchoring protein that facilitates their interaction (8) . ␤ 1 -Adrenergic receptors (␤ 1 ARs), however, are phosphorylated in equal measure by PKA and GRK2, with PKA-phosphorylated receptors targeted to caveolae and internalized via a ␤-arrestinindependent pathway (9, 39) . Among class II receptors, G s protein-coupled secretin receptors are preferentially phosphorylated by PKA and internalized via a GRK2/␤-arrestin/clathrin-independent endocytic pathway (12, 42, 46) . Their close homologs, vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activing peptide (PACAP) receptors (VPAC 1 receptors), which possess equally high affinity for VIP and PACAP, are phosphorylated by GRK2 and internalized via a ␤-arrestin/clathrin-dependent pathway (17, 25, 43) . This mechanism is obscured in cell lines overexpressing VPAC 1 receptors, underlining the importance of studies on constitutively expressed receptors (43) . PKA inhibitors have no effect on VPAC 1 receptor phosphorylation, suggesting that PKA does not participate directly or indirectly in VPAC 1 receptor phosphorylation (17) . VPAC 2 receptors also appear to be internalized via a clathrin pathway, but the roles of GRK2 and PKA in receptor phosphorylation and internalization have not been characterized (26, 27) .
Here, we show that G s protein-coupled VPAC 2 receptors, predominantly expressed in smooth muscle cells of the gut (6, 44) , are exclusively phosphorylated by GRK2 and that feedback phosphorylation of GRK2 at Ser 685 by PKA leads to an increase in GRK2 activity and thus augments GRK2-mediated receptor phosphorylation, internalization, and desensitization of the functional response.
MATERIALS AND METHODS
Preparation of dispersed gastric smooth muscle cells. Gastric smooth muscle cells were isolated from the circular muscle layer of the rabbit stomach by sequential enzymatic digestion, filtration, and centrifugation as previously described (29, 32, 33) . The Virginia Commonwealth University Institutional Animal Care and Use Committee approved the use of animals and protocol used in this study. Briefly, muscle strips were incubated at 31°C for 20 min in HEPES medium with type II collagenase (0.1%) and soybean trypsin inhibitor (0.1%). The partly digested strips were washed, muscle cells were allowed to disperse spontaneously for 30 min, and cells harvested by filtration though 500-m Nitex and centrifuged twice at 350 g for 10 min. Dispersed smooth muscle cells were cultured in DMEM containing 10% FBS until they attained confluence and were then passaged once for use in various studies (13, 14) .
Vector and GRK2 mutant constructs. Wild-type GRK2, dominant negative GRK2 [i.e., kinase-deficient GRK2(K220R)], PKA phosphorylation site-deficient GRK2(S685A), and the COOH-terminal fragment of GRK2 (GRK2 495-689 ) were subcloned separately into the multiple cloning site (EcoRI) of the eukaryotic expression vector pEXV. A Myc tag was incorporated into the NH 2 terminus of GRK2 constructs. Recombinant plasmid DNAs (2 g each) were transiently transfected into smooth muscle cells in the first passage by incubation with Lipofectamine Plus reagent for 48 h. Cells were cotransfected with 1 g of pGreen Lantern-1 to monitor expression. Control cells were cotransfected with 2 g of vector (pEXV) and 1 g of pGreen Lantern-1 DNA. The transfection efficiency (ϳ75%) was monitored by the expression of green fluorescent protein using FITC filters (13, 14) .
Phosphorylation of VPAC 2 receptors and GRK2. Phosphorylation of VPAC2 receptors and GRK2 was determined from the amount of 32 P incorporated into the protein after immunoprecipitation with specific GRK2, Myc, or VPAC2 receptor antibody. GRK2 was immunoprecipitated with GRK2 antibody in freshly dispersed muscle cells and with Myc antibody in cultured muscle cells overexpressing GRK2 constructs. Ten milliliters of smooth muscle cell suspension (3 ϫ 10 6 cells/ml) were incubated with [ 32 P]orthophosphate for 4 h at 31°C. Samples (1 ml) were then incubated with VIP (1 M) for 5 min. Cell lysates were separated by centrifugation at 13,000 g for 10 min at 4°C, precleared with 40 l of protein A-Sepharose, and incubated for 2 h at 4°C with antibody to VPAC 2 receptors, GRK2, or Myc and with 40 l of protein A-Sepharose for another 1 h. Immunoprecipitates were extracted with Laemmli sample buffer, boiled for 5 min, and separated by electrophoresis by SDS-PAGE. After a transfer to polyvinylidene difluoride (PVDF) membranes, [ 32 P]GRK2 or [ 32 P]VPAC2 was visualized by autoradiography, and the amount of radioactivity in the band was measured. Results are expressed as counts per minute (14, 30) .
GRK2 and VPAC 2 receptor phosphorylation were also measured in nonlabeled cells using a phosphosubstrate antibody specific for PKA phosphorylation sites. GRK2 was immunoprecipitated with GRK2 antibody in freshly dispersed muscle cells and with Myc antibody in cultured muscle cells overexpressing GRK2 constructs. The VPAC 2 receptor was immunoprecpitated with VAPC2 antibody. Immunoprecipitates were separated by SDS-PAGE, transferred to PVDF membranes, and probed with PKA phosphosubstrate antibody. After an incubation with secondary antibody, proteins were visualized by enhanced chemiluminescence (ECL), and the intensity of the protein band on ECL film was determined by densitometry.
G␤:GRK2 association. Smooth muscle cells (3 ϫ 10 6 cells/ ml) treated with VIP and/or forskolin were lysed by an incubation for 30 min at 4°C in 10 mM Tris (pH 7.5), 50 mM NaCl, 1% Triton X-100, and 60 mM octyl glucoside, and lysates were centrifuged at 15,000 g for 30 min. The supernatant was precleared by an incubation with 40 l of protein A-Sepharose for 4 h and then incubated overnight with the antibody to GRK2. Protein A-Sepharose was then added, and the mixture was incubated for 2 h and then centrifuged at 13,000 g for 5 min. Immunoprecipitates were washed four times in lysis buffer and boiled in Laemmli buffer. Samples were separated by SDS-PAGE, transferred to PVDF membranes, and probed with the antibody to common G␤. After an incubation with secondary antibody, proteins were visualized by ECL, and the intensity of the protein band on ECL film was determined by densitometry.
Receptor internalization, recycling, and degradation. Binding of 125 I-labeled VIP ( 125 I-VIP) to cultured muscle cells was performed as previously described (6, 13, 24, 29) . Muscle cells were detached from culture dishes by an incubation with 0.53 mM EDTA in PBS at 37°C for 30 min. Cells were collected by centrifugation at 400 g and resuspended in DMEM containing BSA (0.1%), amastatin (10 M), and phospharamidon (1 M). Triplicate 0.5-ml (2 ϫ 10 6 cell/ml) aliquots were incubated for 60 min at 4°C with 50 pM 125 I-VIP alone or in the presence of 10 M VIP. Bound and free radioligands were separated by rapid filtration under reduced pressure through 5-m polycarbonate Nucleophore filters. Nonspecific binding (32 Ϯ 6%) was calculated as the amount of radioactivity in the presence of 10 M VIP.
Receptor internalization was determined by incubating muscle cells with VIP at 37°C for different time periods; cells were then washed twice with PBS at 4°C to avoid further receptor internalization and recycling, and 125 I-VIP binding to residual surface VAPC2 receptors was measured for 60 min at 4°C and compared with control 125 I-VIP binding in the absence of treatment with VIP.
Receptor recycling was determined by treating muscle cells with 10 M VIP for 30 min at 37°C to promote internalization. Ligands and receptors remaining on the cell surface were removed by two washes with 150 mM NaCl plus 5 mM acetic acid and three washes with PBS (all at 4°C), and cells were then allowed to recover for different time periods at 37°C. At the end of each recovery period, cells were resuspended in control medium at 4°C, and 125 I-VIP binding to the recycled surface receptors was determined for 60 min.
Receptor degradation was determined from residual 125 I-VIP binding after a prolonged 5-h exposure to VIP. At intervals of 1 h, 125 I-VIP binding was determined in cells expressing wild-type or mutant GRK2. Amounts of VPAC2 receptors at each interval were determined by Western blot analysis.
Biotin labeling of surface receptors. Receptor internalization was also measured by biotinylation of cell surface receptors. Muscle cells were incubated with VIP at 37°C for different time periods; cells were then washed twice with PBS at 4°C followed by treatment with 10 mM sodium periodate for 30 min in the dark. After being washed with PBS, cells were incubated for 30 min at 4°C with membraneimpermeable biotin LC-hydrazide (2 mM) to conjugate glycoproteins with biotin. Cells were then solubilized in lysis buffer, and the insoluble material was removed by centrifugation; soluble extracts were incubated with antibody to VAPC2 receptors. VPAC2 receptor immunoprecipitates were extracted with Laemmli sample buffer, boiled for 5 min, separated by electrophoresis with SDS-PAGE, and transferred to nitrocellulose membranes. After incubation of the membrane with horseradish peroxidase-conjugated streptavidin, proteins were visualized by ECL.
Assay for GRK2 activity. GRK2 activity was measured in immunoprecipitates of GRK2 using rhodopsin as the substrate, as previously described (7) . One-milliliter aliquots (3 ϫ 10 6 cells/ml) of muscle cells were incubated with VIP for 5 min, and GRK2 was immunoprecipitated using GRK2 antibody in freshly dispersed cells or Myc antibody in cultured muscle cells. Immunoprecipitates were washed with phosphorylation buffer containing 10 mM MgCl2 and 40 mM HEPES (pH 7.4) and then incubated for 30 min with 1 M rhodopsin. Kinase assays were initiated by the addition of kinase buffer containing 30 mM Tris ⅐ HCl (pH 7.2), 8 mM MgCl2, 1.4 mM EDTA, 1 mM EGTA, 10 Ci of [␥-
32 P]ATP (3,000 Ci/mmol), and 160 M ATP, and the reaction was stopped with SDS sample buffer. Phosphorylated proteins were resolved by SDS-PAGE and quantitated.
Assay for adenylyl cyclase activity. Adenylyl cyclase activity was measured using [␣-
32 P]ATP as the substrate, as previously described (32, 33) . Crude homogenates of dispersed gastric muscle cells were incubated for 15 min at 37°C in 50 mM Tris ⅐ HCl (pH 7.4), 2 mM cAMP, 0.1 mM ATP, 1 mM IBMX, 5 mM MgCl 2, 100 mM NaCl, 5 mM creatine phosphate, 50 U/ml creatine phosphokinase, and 0. 5 mM [␣-
32 P]ATP. The [ 32 P]cAMP produced was collected by sequential chromatography on Dowex AG50W-4X and alumina columns. Results are expressed as picomoles of cAMP per milligram of protein per minute.
Radioimmunoassay for cAMP. cAMP levels were measured by radioimmunoassay, as previously described (29, 33) . Suspensions of smooth muscle cells (10 6 cells/ml) were stimulated for 1 min with 1 M VIP in the presence of 100 M IBMX, and the reaction was terminated with 10% trichloroacetic acid. Samples were centrifuged, and the supernatant was extracted with diethyl ether and lyophilized.
Samples were resuspended in Na-acetate buffer (pH 6.2) followed by acetylation with triethylamine-acetic anhydride for 10 min. cAMP was measured in duplicate using 100-l aliquots, and the results are expressed as picomoles per milligram of protein.
Materials. 125 I-VIP, [␣-32 P]ATP, 125 I-labeled-cAMP, and [ 32 P]-orthophosphate were obtained from NEN Life Sciences Products (Boston, MA); polyclonal antibodies to GRK2, VPAC 2 receptors, and hemaglutinin (HA) were from Santa Cruz Biotechnology (Santa Cruz, CA); and monoclonal antibody to PKA phosphosubstrate was from Cell Signaling Technology (Beverly, CA). Western blot and chromatography material were from Bio-Rad Laboratories (Hercules, CA); collagenase and soybean trypsin inhibitor were from Worthington Biochemical (Freehold, NJ); and all other reagents were from Sigma.
RESULTS

Feedback phosphorylation of GRK2 by PKA.
We have recently shown that the selective activation of PKA with a low concentration (1 M) of isoproterenol induced GRK2 phos- Fig. 1 . Concentration-dependent phosphorylation of G protein-regulated kinase 2 (GRK2) induced by vasoactive intestinal peptide (VIP) in smooth muscle. Freshly dispersed gastric smooth muscle cells labeled with 32 P were incubated with VIP (0.1 nM to 1 M) for 5 min and then lysed, and GRK2 was immunoprecipitated with GRK2 antibody. GRK2 phosphorylation was identified in immunoprecipitates by autoradiography. Immunoblot analysis showed equal amounts of loaded protein. Radioactivity in the protein bands was expressed as the increase in counts per minute (cpm) above basal levels (502 Ϯ 87 cpm). p-GRK2, phosphorylated GRK2. Values are expressed as means Ϯ SE of 4 experiments. **P Ͻ 0.001, significant increase in GRK2 phosphorylation. Fig. 2 . Blockade of VIP-induced GRK2 phosphorylation in cells expressing GRK2(S685A). Cultured smooth muscle cells expressing Myc-tagged wild-type (WT) GRK2 (control) or Myc-tagged phosphorylation-deficient GRK2(S685A) were treated with VIP (1 M) for 5 min, and GRK2 was immunoprecipitated using the antibody to Myc. A: GRK2 phosphorylation was determined by autoradiography in GRK2 immunoprecipitates isolated from 32 Plabeled cells and expressed as cpm. B: GRK2 phosphorylation was also determined in GRK2 immunoprecipitates isolated from nonlabeled cells using phospho-specific antibody to PKA phosphorylation sites. Immunoblot analysis showed equal amount of loaded protein. Values are expressed as means Ϯ SE of 4 experiments. A, inset: levels of GRK2 phosphorylation and expression were examined in GRK2 immunoprecipates prepared from freshly dispersed muscle cells using GRK2 antibody (lane 1) and in cells overexpressing WT GRK2 using the antibody to Myc (lane 2) and GRK2 (lane 3).
phorylation at Ser 685 in freshly dispersed and cultured gastric smooth muscle cells, whereas the selective activation of PKG with sodium nitroprusside had no effect (14) . VIP interacts with both cognate G s protein-coupled VPAC 2 receptors and single-transmembrane G i1 /G i2 protein-coupled NPR-C receptors in gastric smooth muscle cells to generate cAMP and cGMP, respectively, and activate both PKA and PKG (29, 48) . In the present study, treatment of 32 P-labeled cultured gastric smooth muscle cells with VIP induced phosphorylation of GRK2 in a concentration-dependent fashion (Fig. 1) . GRK2 phosphorylation, measured in immunoprecipitates using the antibody to Myc, was blocked in cells expressing PKA phosphorylation site-deficient GRK2(S685A) (Fig. 2A) . Phosphorylation levels in cells overexpressing wild-type GRK2 appeared to be similar to that of freshly dispersed muscle cells, reflecting the low efficiency of the Myc antibody used to immunoprecipitate GRK2. However, when GRK2 was immunoprecipitated with the antibody to GRK2, phosphorylation and expression levels of GRK2 were greater, suggesting overexpression of GRK2 ( Fig. 2A, inset) . Selective phosphorylation of GRK2 by PKA was corroborated using a phosphosubstrate antibody specific for PKA phosphorylation sites: phosphorylation of GRK2 was blocked in cells expressing GRK2(S685A) (Fig. 2B) .
cAMP generated in smooth muscle cells is degraded by two cAMP-specific phosphodiesterases (PDEs), PDE3A and PDE4D5 (33) . VIP (10 nM) caused an increase (65 Ϯ 5% increase above basal levels of 3.98 Ϯ 0.45 pmol/mg protein) in cAMP levels, and the increase was significantly augmented (136 Ϯ 15% increase above basal levels) by a combination of the PDE3 inhibitor milrinone (10 M) and the PDE4 inhibitor rolipram (10 M). Blockade of cAMP degradation by the combination of milrinone (10 M) and rolipram (10 M) significantly augmented GRK2 phosphorylation induced by a low concentration of VIP (10 nM), providing further support for the notion that phosphorylation was mediated via a feedback mechanism involving the activation of PKA (Fig. 3A) .
Interdependence of GRK2 phosphorylation and GRK2:G␤␥ association. Since G protein ␤␥-subunits assist in the targeting of GRK2 to the membrane-bound receptor, we examined the effect of G␤␥:GRK2 association on GRK2 phosphorylation by PKA and the effect of GRK2 phosphorylation on G␤␥:GRK2 association. VIP-induced GRK2 phosphorylation was significantly inhibited in smooth muscle cells expressing G␤␥-scav- enging peptide (COOH-terminal fragment of GRK2), suggesting that binding of G␤␥ to GRK2 augments GRK2 phosphorylation by PKA (Fig. 3B) .
Conversely, G␤␥:GRK2 association induced by VIP was significantly inhibited in smooth muscle cells expressing GRK2(S685A), suggesting that phosphorylation of GRK2 by PKA augments the GRK2 association with G␤␥ (Fig. 4) . Forskolin, which activates adenylyl cyclase directly, had no effect on GRK2:G␤␥ association or GRK2 phosphorylation but augmented GRK2:G␤␥ association and GRK2 phosphorylation induced by a low concentration of VIP (Fig. 5) . These results imply that GRK2:G␤␥ association and GRK2 phosphorylation were reciprocally regulated and were dependent on receptor activation: phosphorylation of GRK2 increased its association with G␤␥, which, in turn, enhanced GRK2 phosphorylation by PKA.
To determine whether the phosphorylation of GRK2 affects its activity, we measured the activity of GRK2 in response to VIP in both freshly dispersed muscle cells and cells expressing wild-type GRK2 and GRK2(S685). VIP caused an increase in GRK2 activity that was significantly attenuated by blockade of PKA with myristoylated protein kinase inhibitor (PKI), suggesting that the phosphorylation of GRK2 by PKA augmented GRK2 activity (Fig. 6) . VIP also caused an increase in GRK2 activity in cultured muscle cells expressing wild-type GRK2 and GRK2(S684). However, the increase in GRK2 activity was significantly inhibited in cells expressing GRK2(S685A), providing further support for the notion that PKA-mediated phosphorylation augmented GRK2 activity (Fig. 6) . 5 . Dependence of GRK2:G␤␥ association and GRK2 phosphorylation on receptor activation. Smooth muscle cells were treated with forskolin (10 M), VIP (10 nM), or forskolin and VIP for 5 min. Cells were lysed, and GRK2 was immunoprecipitated with GRK2 antibody. A: GRK2:G␤␥ association was determined in GRK2 immunoprecipitates by immunoblot analysis with a common G␤ antibody. B: GRK2 phosphorylation was determined by immunoblot analysis with phospho-specific antibody to PKA phosphorylation sites. Values are expressed as means Ϯ SE of 4 experiments. **P Ͻ 0.01, significant increase in GRK2:G␤␥ association and VIP-induced GRK2 phosphorylation in the presence of forskolin. Fig. 6 . Stimulation of GRK2 activity by PKA. A: freshly dispersed muscle cells were treated with VIP (1 M) for 5 min in the presence or absence of protein kinase inhibitor (PKI; 1 M), and GRK2 was immunoprecipitated using GRK2 antibody. B: cultured smooth muscle cells expressing Myc-tagged WT GRK2 (control) or GRK2(S685A) were treated with VIP (1 M) for 5 min, and GRK2 was immunoprecipitated using Myc antibody. GRK2 activity toward rhodopsin was measured as described in MATERIALS AND METHODS. **Significant attenuation of VIP-induced GRK2 activity by PKI or in cells expressing GRK2(S685A). 2 receptor phosphorylation. VIP induced phosphorylation of VPAC 2 receptors, and the phosphorylation was abolished in cells expressing GRK2(K220R) and partly inhibited in cells expressing GRK2(S685A), implying that the ability of GRK2 to phosphorylate VPAC 2 receptors is partly dependent on its phosphorylation by PKA (Fig. 7) . No phosphopeptide band was detected in VPAC 2 receptor immunoprecipitates using phosphosubstrate antibody specific for PKA phosphorylation sites, confirming that VPAC 2 receptors were phosphorylated by GRK2 but not by PKA. Furthermore, receptorindependent activation of PKA with forskolin had no effect on VPAC 2 receptor phosphorylation, but it augmented VPAC 2 receptor phosphorylation induced by a low concentration of VIP (10 nM; Fig. 8 ). Similar results were obtained with a cAMP analog, Sp-5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole-3Ј,5Ј-monophosphorothioate, which selectively activates PKA (data not shown). These results show that VPAC 2 receptors were phosphorylated exclusively by GRK2 and that GRK2 activity was augmented upon its feedback phosphorylation by PKA.
Phosphorylation of GRK2 by PKA augments VPAC
Phosphorylation of GRK2 by PKA augments VPAC 2 receptor internalization. VPAC 2 receptor internalization was assessed by the decrease in 125 I-VIP binding to surface receptors after treatment with 1 M unlabeled VIP. Pretreatment of cultured smooth muscle cells with VIP caused a decrease in 125 I-VIP binding that was completely reversed in cells expressing GRK2(K220R) and partly reversed in cells expressing GRK2(S685A), suggesting that receptor internalization was mediated by GRK2 and that the effect of GRK2 was augmented upon its phosphorylation by PKA (Fig. 9) .
In cells expressing wild-type GRK2, receptor internalization (decrease in receptor binding to 125 I-VIP after a 30-min exposure to the ligand) was dependent on the concentration of VIP and was significantly attenuated in cells expressing GRK2(S685A) (Fig. 10A) . VPAC 2 receptor internalization was rapid [half-time (t 0.5 ): ϳ7 min] and maximal after a 20-min exposure to VIP (21 Ϯ 3% surface receptors and 76 Ϯ 4% internalized receptors; Fig. 10B ). In cell expressing GRK2(S685A), however, VPAC 2 receptor internalization was slower (t 0.5 : ϳ20 min), and the maximal number of internalized receptors after a 30-min exposure to VIP was significantly lower (56 Ϯ 6% surface receptors and 42 Ϯ 5% internalized receptors; Fig. 10B) .
A similar time course for VPAC 2 receptor internalization was observed after biotin labeling of surface VPAC 2 receptors.
Treatment of cells expressing wild-type GRK2 with VIP caused a rapid decrease in surface VPAC 2 receptors (t 0.5 : ϳ10 min) and a maximal decrease after 30 min (ϳ80% decrease in surface receptors). In cell expressing GRK2(S685A), however, VAPC 2 receptor internalization was slower (t 0.5 : ϳ30 min), and the maximal decrease in surface receptors after a 30-min exposure to VIP was significantly lower (ϳ50% decrease; Fig. 11 ).
Receptor recycling was determined after a 30-min exposure to VIP followed by a 60-min washout period; at 10-min intervals during this period, 125 I-VIP binding to surface receptors was measured. In cells expressing wild-type GRK2, recycling was virtually complete within 60 min, whereas in cells expressing GRK2(S685A) recycling was complete within 30 min (Fig. 10B) .
Receptor degradation determined from residual 125 I-VIP binding after prolonged exposure to VIP in cells expressing wild-type GRK2 was minimal during the first hour and increased progressively to 80% after 5 h (Fig. 12) . Degradation was greatly reduced (ϳ50% after 5 h) in cells expressing GRK2(S685A) and was undetectable in cells expressing kinase-deficient GRK2(K220R). The pattern of receptor degradation was corroborated by immunoblot analysis of VPAC 2 receptors.
Phosphorylation GRK2 by PKA augments VPAC 2 receptor desensitization. Desensitization of the response mediated by VPAC 2 receptors was determined by direct measurement of adenylyl cyclase activity. VIP stimulated adenylyl cyclase activity of cultured smooth muscle cells in a concentrationdependent fashion (EC 50 : 3 nM; maximal effect at 1 M VIP). After treatment of the cells with 1 M VIP for 30 min, adenylyl cyclase activity decreased significantly at all concentrations: the response to 1 nM VIP was abolished, and the response to 1 M VIP was inhibited by 60% (Fig. 13) . There was no desensitization of VIP-stimulated adenylyl cyclase activity in cells expressing GRK2(K220R) and only partial desensitization in cells expressing GRK2(S685A) (Fig. 13) . Similarly, VIP-stimulated cAMP generation was significantly inhibited after treatment of the cells with 1 M VIP for 30 min (data not shown). There was no desensitization of the cAMP response in cells expressing GRK2(K220R) and only partial desensitization in cells expressing GRK2(S685A) (data not shown). These results implied that VIP-induced desensitization resulted from GRK2-mediated phosphorylation and internalization of VPAC 2 receptors, which were augmented via PKAmediated GRK2 phosphorylation.
The notion that phosphorylation of GRK2 was mediated by PKA leading to increase in GRK:G␤␥ association and GRK2-mediated VPAC 2 receptor phosphorylation, internalization, and desensitization was corroborated using the membranepermeable specific PKA inhibitory peptide myristolylated PKI (14 -22) amide. PKI contains the PKA pseudosubstrate sequence and specifically inhibits PKA catalytic activity by binding to the substrate binding site. Treatment of cells with PKI blocked VIP-induced GRK2 phosphorylation and partially inhibited GRK2:G␤␥ association and GRK2-mediated VPAC 2 receptor phosphorylation (Fig. 14) . PKI also partially inhibited the VIP-induced VPAC 2 receptor internalization and desensitization (Fig. 14) .
DISCUSSION
The extent to which second messenger-activated protein kinases such as PKA participate in receptor phosphorylation and internalization varies greatly among receptors. As noted above, agonist-occupied ␤ 2 ARs are preferentially phosphorylated by PKA at low agonist concentrations and jointly by PKA and GRK2 at higher concentrations, whereas ␤ 1 ARs are phosphorylated in equal measure by PKA and GRK2, with PKAphosphorylated receptors targeted to caveolae for internalization (4, 7, 9, 10, 39, 45) . Among class II receptors, secretin receptors can be phosphorylated by GRK2 in vitro, yet are preferentially phosphorylated by PKA in vivo and internalized via an endocytic pathway that is independent of GRK2, ␤-arrestin, or dynamin (12, 42, 46) . In contrast, constitutively expressed VPAC 1 receptors are phosphorylated by GRK2 and internalized via a ␤-arrestin/dynamin-dependent pathway; neither phosphorylation nor internalization of VPAC 1 receptors is affected by PKA inhibitors (17, 25, 43) .
We have previously shown that smooth muscle cells of the gut express predominantly VPAC 2 receptors (6, 44) . Here, we show that VPAC 2 receptors differ from their homologs, secre- tin and VPAC 1 receptors, as well as from class I receptors. VPAC 2 receptors, like VPAC 1 receptors, are phosphorylated exclusively by GRK2 but, unlike secretin and ␤-adrenergic receptors, are not directly phosphorylated by PKA. Expression of kinase-deficient GRK2(K220R) abrogates VPAC 2 receptor phosphorylation and internalization. PKA regulates VPAC 2 receptor phosphorylation indirectly via GRK2 phosphorylation at Ser 685 ; this modification enhanced the recruitment of GRK2 by G␤␥ to the plasma membrane in proximity to VPAC 2 receptors and thus augmented VPAC 2 receptor phosphorylation. A similar mechanism contributes to the component of ␤ 2 AR phosphorylation that is mediated by GRK2 (7).
The inability of PKA to phosphorylate unoccupied or VIPoccupied VPAC 2 receptors directly was evident in experiments where forskolin alone did not induce VPAC 2 receptor phosphorylation. In the presence of VIP, however, forskolin augmented GRK2 phosphorylation, GRK2:G␤␥ association, and receptor phosphorylation.
The essential role of GRK2 and the augmentatory role of PKA-mediated GRK2 phosphorylation were reflected in measurements of GRK2 activity and VPAC 2 receptor internalization, recycling, and degradation as well as in the desensitization of the functional response to VIP. VIP-induced phosphorylation of GRK2 was blocked by PKI in freshly dispersed cells and by expression of GRK2(S685A) in cultured muscle cells. Internalization, determined from the decrease in 125 I-VIP binding to VPAC 2 receptors, was abolished in cells expressing kinasedeficient GRK2(K220R) and significantly inhibited in cells expressing PKA phosphorylation site-deficient GRK2(S685A). A similar inhibition was observed in experiments where VPAC 2 receptors were labeled with biotin. VPAC 2 receptor degradation, observed only upon prolonged exposure to VIP (1-5 h), reflected the pattern of receptor internalization and was significantly decreased in cells expressing GRK2(S685A) and undetectable in cells expressing kinase-deficient GRK2(K220R). Desensitization of the functional response (adenylyl cyclase activity and cAMP generation) also followed the pattern of internalization by decreasing in cells expressing GRK2(S685A) and was absent in cells expressing kinase-deficient GRK2(K220R). The effect of GRK2(S685) expression on VPAC 2 receptor phosphorylation, internalization, and desensitization was mimicked by the selective blockade of PKA activity.
The binding of PKA to AKAP at the inner surface of the plasma membrane and the recruitment of GRK2 by G␤␥ to the plasma membrane should foster the interaction of the two Fig. 15 . Homologous desensitization of VPAC2 receptors is augmented by feedback phosphorylation of GRK2 via PKA. Activation of Gs protein-coupled VPAC2 results in cAMP generation and PKA activation via the ␣-subunit. Recruitment of GRK2 via G␤␥ results in VPAC2 receptor phosphorylation, internalization, and homologous desensitization. Feedback phosphorylation of GRK2 by PKA increases G␤␥ and GRK2 association, leading to the augmentation of VPAC2 receptor phosphorylation, internalization, and homologous desensitization.
- Fig. 14 . Effect of PKA inhibitor (PKI) on the phosphorylation of GRK2 and its association with G␤␥ as well as VPAC2 phosphorylation, internalization, and desensitization induced by VIP. VIP-induced GRK2 phosphorylation, GRK2:G␤␥ association, and VPAC2 phosphorylation, internalization, and desensitization were measured in the presence or absence of myristolylated PKI, as described in MATERIALS AND METHODS. GRK2 phosphorylation was measured in cells labeled with 32 P and in nonlabeled cells. VPAC2 receptor internalization was assessed by the decrease in kinases. In this study, binding of G␤␥ to GRK2 enhanced phosphorylation of GRK2 by PKA; in turn, phosphorylation of GRK2 enhanced its binding to G␤␥. This interdependence was evident by the decrease of GRK2 phosphorylation in cells expressing G␤␥-scavenging peptide and by the decrease in G␤␥:GRK2 association in cells expressing GRK2(S685A).
It is possible, as proposed by Cong et al. (7) for ␤ 2 ARs, that AKAP79/150 acts as a scaffold that binds receptor and PKA (but not GRK2) and facilitates phosphorylation of receptor or GRK2 by PKA. While AKAP79/150 is an appropriate scaffold for receptor substrates of PKA such as ␤ 2 ARs, a more plausible candidate where VPAC 2 receptors are concerned is caveolin, which is known to act as a scaffold that binds various signaling proteins including receptors (e.g., ␤ 2 AR), activated G protein subunits, AKAP79/150, adenylyl cyclase V/VI, GRK2, PKC isozymes (PKC-␣ and PKC-ε), L-type Ca 2ϩ channel protein, and phosphatase 2B (3, 5, 15, 16, 28, 31, 34 -36, 41, 47) . In gastric smooth muscle homogenates, caveolin-3, adenylyl cyclase V/VI, PKA, GRK2, PKC-ε, phosphatase 2B, and voltage-gated Ca 2ϩ channel protein coimmunoprecipitated with AKAP79/150 (K. S. Murthy, unpublished observations).
In summary, G s protein-coupled VPAC 2 receptor phosphorylation, internalization, and desensitization exhibit features that distinguish VPAC 2 receptors from other G s protein-coupled class I and II receptors. VPAC 2 receptor phosphorylation is mediated exclusively by GRK2 (Fig. 15) . Feedback phosphorylation of GRK2 by PKA enhances GRK2 activity and its ability to mediate VPAC 2 receptor phosphorylation, internalization, desensitization, and degradation.
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